[EFFECT] NERVGEN PHARMA CORP. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT 05/27/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: May 26, 2026 4:00 P.M. Form: F-10 CIK: 0001751912 Company Name: NERVGEN PHARMA CORP. File Number: 333-296217 Source: View Original Filing on SEC EDGAR